ENDRA Life Sciences (NDRA) Reports In-Line Q1 EPS

ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Radnostix revenue falls 27% amid product recalls and FDA actions
• Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)